Cargando…
Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer
BACKGROUND: Current cancer immunotherapies have made tremendous impacts but generally lack high response rates, especially in ovarian cancer. New therapies are needed to provide increased benefits. One understudied approach is to target the large population of immunosuppressive tumor-associated macr...
Autores principales: | Glass, Evan B., Hoover, Alyssa A., Bullock, Kennady K., Madden, Matthew Z., Reinfeld, Bradley I., Harris, Whitney, Parker, Dominique, Hufnagel, Demetra H., Crispens, Marta A., Khabele, Dineo, Rathmell, W. Kimryn, Rathmell, Jeffrey C., Wilson, Andrew J., Giorgio, Todd D., Yull, Fiona E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074180/ https://www.ncbi.nlm.nih.gov/pubmed/35513776 http://dx.doi.org/10.1186/s12885-022-09612-2 |
Ejemplares similares
-
Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer
por: Hoover, Alyssa A., et al.
Publicado: (2020) -
Untangling ccRCC prognosis with SLINKY
por: Reinfeld, Bradley I., et al.
Publicado: (2017) -
The therapeutic implications of immunosuppressive tumor aerobic glycolysis
por: Reinfeld, Bradley I., et al.
Publicado: (2021) -
Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis
por: Hufnagel, Demetra H., et al.
Publicado: (2020) -
Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2021)